NEW YORK, March 15, 2019 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds
investors in Syneos Health, Inc. ("Syneos" or the "Company")(NASDAQ:SYNH) of the April 30, 2019 deadline to seek the role of
lead plaintiff in a federal securities class action that has been filed against the Company.
If you invested in Syneos stock or options between May 10, 2017 and February 27, 2019 and would like to discuss
your legal rights, click here: www.faruqilaw.com/SYNH. There is no cost or obligation to you.
You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at
212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.
CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330
The lawsuit has been filed in the U.S. District Court for the District of New Jersey on behalf of all those who purchased Syneos
securities between May 10, 2017 and February 27, 2019 (the "Class Period"). The case, Murakami v. Syneos Health, Inc. et
al, No. 19-cv-07377 was filed on 3/1/2019, and has been assigned to Michael A. Shipp.
The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading
statements and/or failing to disclose that: (1) Syneos’s internal control over financial reporting was inadequate; (2) concerns
regarding Syneos’s internal control over financial reporting would result in heightened regulatory scrutiny and an SEC
investigation into the Company’s revenue accounting policies, internal controls and related matters; and (3) as a result,
Defendants’ statements about Syneos’s business, operations, and prospects were materially false and/or misleading and/or lacked a
reasonable basis at all relevant times.
On February 27, 2019, after market hours, the Company announced it was delaying the release of its Form 10-K for the year ended
December 31, 2018 after the Securities and Exchange Commission (“SEC”) notified the Company it was investigating its revenue
accounting policies and internal controls. The Company stated its management and Audit Committee were each conducting a review of
the Company’s internal controls and/or accounting policies, amongst other things.
On this news, Syneos's share price fell from $52.01 per share on February 27, 2019 to a closing price of $41.77 on February 28,
2019: a $10.14 or a 19.69% drop.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is
adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the
putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and
remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff
or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Syneos's conduct to contact the firm, including
whistleblowers, former employees, shareholders and others.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results
do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your
particular case. All communications will be treated in a confidential manner.
